Genmab Announces European Regulatory Submission for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL Biotech Investing
XBiotech Enrolls Final Patient in Phase I Portion of Clinical Study to Evaluate Antibody Treatment for Staphylococcus Aureus Biotech Investing
Vericel Enters Into $10 Million Credit Facility and $5 Million Term Loan Agreement With Silicon Valley Bank Biotech Investing
Matinas BioPharma Granted US Orphan Drug Designation for MAT2501 for Treatment of Non-Tuberculous Mycobacteria Infections Biotech Investing
DBV Technologies Announces Presentation from NIAID-sponsored CoFAR6 Phase II Trial Reaffirming Viaskin(R) Peanut Safety and Efficacy Biotech Investing
UCLA Sells Royalty Rights Connected with Cancer drug to Royalty Pharma for $1.14 billion Biotech Investing
Biohaven Announces Orphan Drug Designation Request Granted for the Treatment of Spinocerebellar Ataxia Biotech Investing
Bio-Path Holdings Announces Completion of the Safety Segment of the Phase II Clinical Trial of BP1001 in Acute Myeloid Leukemia Biotech Investing
